Study on the correlation of alpha fetoprotein half-life and relapse or metastasis of primary hepatocellular carcinoma
10.3969/j.issn.1000-8861.2001.02.018
- VernacularTitle:甲胎蛋白生物半衰期与肝癌复发转移的关系
- Author:
Shulin LIU
;
Weimin QI
;
Bin LI
;
Lijun ZHANG
- Publication Type:Journal Article
- From:
Immunological Journal
2001;(2):135-137
- CountryChina
- Language:Chinese
-
Abstract:
Objective To clarify the correlation of alpha fetoprotein （AFP） half-life （T1／2） with relapse or／and metastasis of primary hepatocellular carcinoma （PHC） after treatment. Methods Determination of AFP content in serum with two steps double McAb sandwich ELISA.Calculation AFP T1／2 of the sufferers treated with intervention and radiofrequency ablation （RFA） according to T1／2=0.3 dT／log（AFP1／AFP2）. Results When AFP T1／2＞11.5 days， the sensitivity， specificity and accuracy of predicting the relapse or metastasis of PHC after treatment were 87.5％， 89.3％， 88.5％， respectively. Intervention group was 82.35％， 83.3％， 82.75％， respectively and RFA group was 93.3％， 93.75％， 93.5％， respectively. During 200 days，there was very significant difference of AFP T1／2 （P＜0.001） between non-relapsed／ non-metastasized and relapsed， metastasized and died. Conclusions AFP T1／2 can be used as a predictive index for relapse， metastasis of PHC after treatment. It is not only a reliable parameter for the later stage treatment， but also a useful index for the evaluation of effect.
